Gide has advised ODDO BHF SCA and H.C. Wainwright & Co, as global coordinators and bookrunners, in connection with Carmat’s capital increase by way of a public offering with a priority subscription period, on an irreducible basis (à titre irréductible) only, to its existing shareholders and a global offering, for an amount (including the issue premium) of €55.7 million.
Carmat, a French company listed on the Euronext growth market operated by Euronext Paris, is the designer and developer of the world’s most advanced total artificial heart project, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure.
The Gide team was led by Arnaud Duhamel, partner, on French law aspects and Guilhem Richard, counsel, assisted by Juliette Pierre and Victor Delion, associates, and by Melinda Arsouze, partner, on U.S. law aspects, assisted by Scott Logan, senior associate. Tax aspects of the transaction were handled by Alexandre Bochu, counsel.
Jones Day advised Carmat. The Jones Day team was led by Charles Gavoty, partner, on French law aspects, assisted by Alexandre Wibaux and Paul Maurin, and by Linda Hesse, partner, on U.S. law aspects, assisted by Seth Engel. Tax aspects of the transaction were handled by Nicolas André, partner, and Célia Rochette.
Gide and Jones Day also advised respectively ODDO BHF SCA and Carmat on previous capital increases of the company in 2017 and 2019.